AptarGroup reported a 6% decrease in sales for the second quarter of 2020, primarily due to the negative impacts of COVID-19 on the beauty and beverage markets. The Pharma segment experienced growth, but it was not enough to offset declines in other segments. Earnings per share decreased by 44% to $0.63, while adjusted earnings per share decreased by 30% to $0.80.
Reported sales and core sales decreased 6% primarily due to COVID-19 impacts.
Pharma segment sales growth of 7% was offset by decreases in Beauty + Home and Food + Beverage.
Thank You Award costs of $3.6 million were included in earnings.
Reported earnings per share totaled $0.63, a 44% decrease year-over-year.
Aptar expects earnings per share for the third quarter of 2020, excluding any restructuring expenses and acquisition-related costs, to be in the range of $0.80 to $0.88. This guidance is based on an effective tax rate range of 28% to 30%.
Visualization of income flow from segment revenue to net income